Anavex Life Sciences Corp (AVXL)

[Franz1969]

Financial Times

Biogen Shares Fall On Alzheimer's Trial Results

David Crow-21 MINUTES AGO

Shares in Biogen fell by almost 10 per cent in after-hours trading as investors poked holes in a trial of an Alzheimer’s medicine that the company had billed as a success.

Investors were unnerved by the fact that patients on lower doses of the drug — which is being developed in conjunction with Japan’s Eisai — declined more quickly than those who received a placebo.

The finding — which was not shared with reporters at an earlier embargoed briefing — appeared to cast uncertainty on the finding that higher doses of the drug could slow the rate at which patients declined.

https://www.ft.com/content/486c67c4-904f-11e8-bb8f-a6a2f7bca546